NCT01998854View on ClinicalTrials.gov

Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation

TerminatedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

January 31, 2015

Conditions
MenorrhagiaLeiomyomaUterine FibroidsUterine FibromaUterine Neoplasms
Interventions
DEVICE

VizAblate System

The VizAblate System is indicated for use in transcervical intrauterine-guided radio frequency ablation of uterine fibroids

Trial Locations (2)

37044

Le Centre Hospitalier Regional et Universitaire de Tours - Hôpital Bretonneau, Tours

75475

Assistance Publique Hôpitaux de Paris - Hôpital Bicêtre, Paris

Sponsors

Lead Sponsor

Gynesonics
All Listed Sponsors
lead

Gynesonics

INDUSTRY